SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-000583
Filing Date
2019-03-14
Accepted
2019-03-14 12:30:24
Documents
4
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 6-K tv516207_6k.htm 6-K 10885
2 EXHIBIT 99.1 tv516207_ex99-1.htm EX-99.1 14162
3 EXHIBIT 99.2 tv516207_ex99-2.htm EX-99.2 252489
4 GRAPHIC tv516207_ex99-1img01.jpg GRAPHIC 16091
  Complete submission text file 0001279569-19-000583.txt   301062
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 19680383
SIC: 2834 Pharmaceutical Preparations